References
- Stamenkovic I, Clark E A, Seed B. A B-lymphocyte activation molecule related to the nerve growth factor receptor and induced by cytokines in carcinomas. EMBOJ 1989; 8: 1403–1410
- Smith C A, Farrah T, Goodwin R G. The TNF receptor super-family of cellular and viral proteins: activation, costimulation and death. Cell 1994; 76: 959–962
- Banchereau J, Bazan F, Blanchard D, et al. The CD40 antigen and its ligand. Annu Rev Immunol 1994; 12: 881–922
- Armitage R J, Fanslow W C, Strockbine L, et al. Molecular and biological characterization of a murine ligand for CD40. Nature 1992; 357: 80–82
- Spriggs M K, Fanslow W C, Armitage R J, Belmont J. The biology of the human ligand for CD40. J Clin Immunol 1993; 13: 373–380
- Noelle R J, Roy M, Shepherd D M, Stamenkovic I, et al. A 39-KDa protein on activated helper T cells binds CD40 and transduces the signal for cognate activation of B cells. Proc Acad Sci USA 1992; 89: 6550–6554
- Lane P, Traunecker A, Hubele S, et al. Activated human T cells express a ligand for human B cell-associated antigen CD40 which participates in T cell-dependent activation of B lymphocytes. Eur J Immunol 1992; 22: 2573–2578
- Armitage R J, Alderson M R. B-cell stimulation. Curr Opin Immunol 1995; 7: 243–247
- Noelle R J. CD40 and its ligand in host defense. Immunity 1996; 4: 415–419
- Mohan C, Shi Y, Laman J D, et al. Interaction between CD40 and its ligand gp39 in the development of murine lupus nephritis. J Immunol 1995; 154: 1470–1480
- Blossom S, Chu E B, Weigle W O, Gilbert K M. CD40 ligand expressed on B cells in the BXSB mouse model of systemic lupus erythematosus. J Immunol 1997; 159: 4580–4586
- Desai-Mehta A, Lu L, Ramsey-Goldman R, et al. Hyperex-pression of CD40 ligand by B and T cells in human lupus and its role in pathogenic autoantibody production. J Clin Invest 1996; 97: 2063–2073
- Koshy M, Berger D, Crow M K. Increased expression of CD40 ligand on systemic lupus erythematosus lymphocytes. J Clin Invest 1996; 98: 826–837
- MacDonald P AK, Nishioka Y, Lipsky P E, Thomas R. Functional CD40 ligand is expressed by T cells in rheumatoid arthritis. J Clin Invest 1997; 100: 2404–2414
- Boots A MH, Wimmers-Bertens A JMM, Rijnders A WM. Antigen-presenting capacity of rheumatoid synovial fibroblasts. Immunology 1994; 82: 268–74
- Rissoan M C, Van Kooten C, Chomarat P, Galibert L, Durand I, Thivolet-Bejui F, Miossec P, Banchereau J. The functional CD40 antigen of fibroblasts may contribute to the proliferation of rheumatoid synovium. Exp Immunol 1996; 106: 481–90
- Early G S, et al. Anti-CD40 ligand antibody treatment prevents the development of lupus-like nephritis in a subset of NZBxNZW mice. J Immunol 1996; 157: 3159–64
- Daikh D I, Finck B K, Linsley P S, Hollenbaugh D, Wofsy D. Long-term inhibition of murine lupus by brief simultaneous blockage of the B7/CD28 and CD40/gp39 costimulation pathways. J Immunol 1997; 159: 3104–3108
- Durie F H, Fava R A, Foy T M, et al. Prevention of collagen-induced arthritis with an antibody to gp39, the ligand for CD40. Science 1993; 261: 1328–1330
- Gerritse K, Lamen J D, Noelle R J, et al. CD40-CD40 ligand interactions in experimental allergic encephalomyelitis and multiple sclerosis. Proc Natl Acad Sci USA 1996; 93: 2499–2504
- Carayanniotis G, Masters S R, Noelle R. J. Suppression of murine thyroiditis via blockade of the CD40-CD40L interaction. Immunol 1997; 90: 421–426
- Buhlmann J E, Noelle R J. Therapeutic potential for blockade of the CD40 ligand, gp39. J Clin Immunol 1996; 16: 83–89